These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20535265)

  • 1. Effect of amlodipine and lisinopril on microalbuminuria in patients with essential hypertension: A prospective study.
    Jalal S; Sofi FA; Abass SM; Alai MS; Bhat MA; Rather HA; Lone NA; Siddiqi MA
    Indian J Nephrol; 2010 Jan; 20(1):15-20. PubMed ID: 20535265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lisinopril and amlodipine on microalbuminuria and renal function in patients with hypertension.
    Ranieri G; Andriani A; Lamontanara G; De Cesaris R
    Clin Pharmacol Ther; 1994 Sep; 56(3):323-30. PubMed ID: 7924128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of treatment effects with an angiotensin converting enzyme inhibitor--lisinopril and a calcium blocker--nifedipine retard on urinary albumin excretion in patients with non-complicated essential hypertension].
    Widecka K; Celibała R; Czekalski S
    Pol Arch Med Wewn; 1995 Feb; 93(2):135-42. PubMed ID: 7479231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients.
    Wu SC; Liu CP; Chiang HT; Lin SL
    Heart Vessels; 2004 Jan; 19(1):13-8. PubMed ID: 14685749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lisinopril and nitrendipine on urinary albumin excretion and renal function in patients with mild to moderate essential hypertension.
    Ogawa Y; Haneda T; Hirayama T; Ide H; Obara A; Maruyama J; Morimoto H; Tanaka H; Kato J; Hayakawa T; Hasebe N; Kikuchi K
    Hypertens Res; 2000 Nov; 23(6):607-12. PubMed ID: 11131273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combination therapy of angiotensin-converting enzyme inhibitor plus calcium channel blocker on urinary albumin excretion in hypertensive microalbuminuric patients with type II diabetes.
    Shigihara T; Sato A; Hayashi K; Saruta T
    Hypertens Res; 2000 May; 23(3):219-26. PubMed ID: 10821130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of pentoxifylline with angiotensin converting enzyme inhibitors produces an additional reduction in microalbuminuria in hypertensive type 2 diabetic patients.
    Harmankaya O; Seber S; Yilmaz M
    Ren Fail; 2003 May; 25(3):465-70. PubMed ID: 12803510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    JAMA; 2002 Dec; 288(23):2981-97. PubMed ID: 12479763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
    Leenen FH; Nwachuku CE; Black HR; Cushman WC; Davis BR; Simpson LM; Alderman MH; Atlas SA; Basile JN; Cuyjet AB; Dart R; Felicetta JV; Grimm RH; Haywood LJ; Jafri SZ; Proschan MA; Thadani U; Whelton PK; Wright JT;
    Hypertension; 2006 Sep; 48(3):374-84. PubMed ID: 16864749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of manidipine and its combination with an ACE inhibitor on insulin sensitivity and metabolic, inflammatory and prothrombotic markers in hypertensive patients with metabolic syndrome: the MARCADOR study.
    Martinez-Martin FJ; Macias-Batista A; Comi-Diaz C; Rodriguez-Rosas H; Soriano-Perera P; Pedrianes-Martin P
    Clin Drug Investig; 2011; 31(3):201-12. PubMed ID: 21155616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of amlodipine and lisinopril on intima-media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial).
    Terpstra WF; May JF; Smit AJ; Graeff PA; Meyboom-de Jong B; Crijns HJ
    J Hypertens; 2004 Jul; 22(7):1309-16. PubMed ID: 15201546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
    Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
    Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study.
    Mogensen CE; Neldam S; Tikkanen I; Oren S; Viskoper R; Watts RW; Cooper ME
    BMJ; 2000 Dec; 321(7274):1440-4. PubMed ID: 11110735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria.
    Fogari R; Mugellini A; Zoppi A; Lazzari P; Destro M; Rinaldi A; Preti P
    Eur J Clin Pharmacol; 2005 Aug; 61(7):483-90. PubMed ID: 16021438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors related to the occurrence of microalbuminuria during antihypertensive treatment in essential hypertension.
    Redon J; Rovira E; Miralles A; Julve R; Pascual JM
    Hypertension; 2002 Mar; 39(3):794-8. PubMed ID: 11897766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of amlodipine, lisinopril, and a combination in the treatment of essential hypertension.
    Naidu MU; Usha PR; Rao TR; Shobha JC
    Postgrad Med J; 2000 Jun; 76(896):350-3. PubMed ID: 10824049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between the effects of amlodipine and lisinopril on proteinuria in nondiabetic renal failure: a double-blind, randomized prospective study.
    Janssen JJ; Gans RO; van der Meulen J; Pijpers R; ter Wee PM
    Am J Hypertens; 1998 Sep; 11(9):1074-9. PubMed ID: 9752892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of renin-angiotensin system inhibition on microalbuminuria in type 2 diabetes: a post hoc analysis of the Shiga Microalbuminuria Reduction Trial (SMART).
    ; Uzu T; Sawaguchi M; Maegawa H; Kashiwagi A
    Hypertens Res; 2008 Jun; 31(6):1171-6. PubMed ID: 18716365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.